Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$15.15 - $21.58 $505,313 - $719,779
-33,354 Reduced 34.12%
64,394 $1.05 Million
Q4 2023

Feb 14, 2024

BUY
$15.75 - $21.38 $457,332 - $620,811
29,037 Added 42.26%
97,748 $2.05 Million
Q3 2023

Nov 14, 2023

BUY
$20.22 - $27.36 $487,928 - $660,224
24,131 Added 54.13%
68,711 $1.46 Million
Q2 2023

Aug 14, 2023

BUY
$19.39 - $28.9 $619,277 - $923,008
31,938 Added 252.63%
44,580 $1.2 Million
Q1 2023

May 15, 2023

BUY
$12.71 - $21.17 $113,538 - $189,111
8,933 Added 240.85%
12,642 $248,000
Q4 2022

Feb 14, 2023

BUY
$11.23 - $19.44 $41,011 - $70,994
3,652 Added 6407.02%
3,709 $50,000
Q3 2022

Nov 14, 2022

SELL
$12.2 - $18.71 $207,705 - $318,537
-17,025 Reduced 99.67%
57 $1,000
Q3 2022

Nov 14, 2022

SELL
$12.2 - $18.71 $207,705 - $318,537
-17,025 Reduced 99.67%
57 $1,000
Q2 2022

Aug 15, 2022

SELL
$12.05 - $22.74 $7,133 - $13,462
-592 Reduced 3.35%
17,082 $225,000
Q1 2022

May 16, 2022

SELL
$18.32 - $23.03 $165,850 - $208,490
-9,053 Reduced 33.87%
17,674 $399,000
Q4 2021

Feb 14, 2022

SELL
$18.75 - $24.8 $382,743 - $506,242
-20,413 Reduced 43.3%
26,727 $594,000
Q3 2021

Nov 15, 2021

BUY
$19.65 - $31.89 $401,076 - $650,906
20,411 Added 76.36%
47,140 $1.01 Million
Q2 2021

Aug 16, 2021

BUY
$29.4 - $35.96 $579,503 - $708,807
19,711 Added 280.86%
26,729 $841,000
Q1 2021

May 17, 2021

SELL
$28.09 - $34.02 $664,216 - $804,436
-23,646 Reduced 77.11%
7,018 $223,000
Q4 2020

Feb 16, 2021

BUY
$20.44 - $30.88 $479,277 - $724,074
23,448 Added 324.94%
30,664 $917,000
Q3 2020

Nov 16, 2020

BUY
$15.68 - $24.28 $113,146 - $175,204
7,216 New
7,216 $171,000
Q2 2020

Aug 14, 2020

SELL
$10.56 - $18.46 $103,688 - $181,258
-9,819 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$8.36 - $22.67 $82,086 - $222,596
9,819 New
9,819 $117,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $443M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.